News

• 

  CRESIB scientists make hey breakthrough that could lead to the eradication of a neglected disease: Yaws

  The Lancet magazine publishes a study in which CRESIB researchers based in Papua New Guinea demonstrate the efficacy of a new oral treatment for yaws [+]

• 

  RTS,S malaria vaccine selected as one of the top ten medical breakthroughs in 2011

  Pedro Alonso points out that the results published in 2011 are the product of more than a decade of work [+]

• 

  World Malaria Report reveals a 25% drop in malaria mortality rates since 2000

  While welcoming this very positive news, CRESIB, one of the participants in this study, stresses the importance of continuing commitment and sustained action [+]

• 

  ISGlobal launches its training programme with a course on imported diseases

  21-25 November, 2011 [+]

• 

  RTS,S malaria vaccine: frequently asked questions

  RTS,S is the most clinically advanced malaria vaccine candidate in the world. [+]

• 

  The first results from ongoing Phase III trial show that malaria vaccine candidate RTS,S reduces the risk of malaria by half in African children aged 5 to 17 months

  The largest clinical trial in children ever conducted in Africa [+]

• Still a long way to go to achieve the health-retalet Millenium Development Goals according to the 7th ECTMIH

  Researchers call for research and developent funding to be maintained at a sustainable level despite the current financial crisis [+]

• Barcelona to host the 7th European Congress of Tropical Medicine and International Health

  This edition's theme is "Global change, migration and health" [+]

• CRESIB's prioritization criteria for AGAUR FI-DGR Grants

  As required in the 2012 call for AGAUR FI-DGR grants, CRESIB has established the criteria that the centre will use to prioritize the presented candidacies, which must also fulfill the requirements demanded by the call. [+]